🔎 Trials Near Me

Akèy › Kolit Ulseratif › Kalifòni

Etid klinik pou Kolit Ulseratif nan Kalifòni

40 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan Kalifòni.

Vil nan Kalifòni

Tèks ofisyèl etid la (Anglè)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Clinnova Research /ID# 280509, Anaheim
  • Southern California Res. Ctr /ID# 280476, Coronado
  • Gastro Care Institute /ID# 281071, Lancaster
  • ak 2 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Gastroenterology and Liver Institute, Escondido
  • United Clinical Research Institute, Murrieta
Ap rekriteFaz 4
Laj 18 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT06581328

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

  • Rady Children's Hospital /ID# 271873, San Diego
  • University of California San Francisco - Mission Bay /ID# 273022, San Francisco
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Sep 30, 2026 · NCT07071519

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Erick Alayo Medical Corp/Gastro SB Clinic, Chula Vista
  • Southern California GI and Liver Centers (SCLC), Coronado
  • Valley View Research, Garden Grove
  • ak 6 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  • Xencor Investigative Site, Palo Alto
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 024, Canoga Park
  • Site 023, La Jolla
  • Site 012, Lancaster
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-018, San Diego
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07845487

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

  • Clinnova Research ( Site 1042), Anaheim
  • Southern California Research Center ( Site 1044), Coronado
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT07463183

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

  • Gastro Care Institute, Lancaster
  • Medical Associates Research Group, Inc., San Diego
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06979336

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • Clinnova Research, Anaheim
  • Southern California Research Center, Coronado
  • Om Research LLC, Lancaster
  • ak 7 plis
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196748

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

  • Loma Linda University Health System, Loma Linda
  • Cedars-Sinai Medical Center, Los Angeles
  • Lucile Packard Children's Hospital, Palo Alto
  • ak 1 plis
Ap rekriteFaz 2/3
Laj 2 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Smart Cures Clinical Research, Anaheim
  • Cedars-Sinai Medical Center, Beverly Hills
  • United Medical Doctors - Los Alamitos, Los Alamitos
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • University of California Davis Comprehensive Cancer Center, Sacramento
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  • Biopharma Informatic, LLC, Los Angeles
  • Om Research LLC, Oxnard
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07483073

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • UCSF Medical Center at Mission Bay, San Francisco
Ap rekriteFaz 3
Laj 2 a 19 · Tout sèks · Mizajou Sep 22, 2026 · NCT04844606

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • Clinnova Research - Anaheim, Anaheim
  • Om Research LLC, Lancaster
  • Biopharma Informatic, LLC, Los Angeles
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07186101

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • Clinnova Research, Anaheim
  • GMC Clinical Research, Folsom
  • Om Research LLC, Temple City
  • ak 1 plis
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  • Cedars-Sinai Medical Center, Los Angeles
  • Hoag Hospital Newport Beach, Newport Beach
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Southern California GI & Liver Centers - Site Number: 8400062, Coronado
  • United Medical Doctors CA - Site Number: 8400044, Murrieta
  • Om Research, LLC - Victorville - Site Number: 8400022, Victorville
Ap rekriteFaz 3
Laj 16 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07185009

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  • Clinnova Research, Anaheim
  • Gastro SB Clinic, Chula Vista
  • United Medical Doctors, Los Alamitos
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07577856

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • FOMAT - Unio Specialty Care Arcadia - Site Number: 8400027, Arcadia
  • Alliance Research Institute - Site Number: 8400008, Canoga Park
  • Southern California GI & Liver Centers - Site Number: 8400062, Coronado
  • ak 13 plis
Ap rekriteFaz 3
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996

Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis

  • Vanda Investigational Site, Chula Vista
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 18, 2026 · NCT07686081

Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation

  • Cedars Sinai Medical Center, Los Angeles
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT07034443

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • Hoag Hospital, Irvine
  • UC San Diego Health, La Jolla
  • Cedars-Sinai, Los Angeles
  • ak 1 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT05230173

BOOM-IBD2 Pivotal Clinical Trial

  • Gastroenterology Medical Clinic (Objective Health), Folsom
  • Center for Colorectal Innovation, Los Angeles
  • Hoag Hospital, Newport Beach
  • ak 1 plis
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Aug 6, 2026 · NCT06571669

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

  • Children's Hospital Of Orange County, Orange
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Aug 3, 2026 · NCT06100289

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

  • Scripps Clinic Torrey Pines, La Jolla
  • United Medical Doctors, Los Alamitos
  • United Medical Doctors, Los Alamitos
Ap rekriteEtid obsèvasyon
Laj 18 a 64 · Tout sèks · Mizajou Jul 9, 2026 · NCT06398626

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

  • Valley View Wellness Medical Center, Garden Grove
  • Loma Linda Children's Hospital, Loma Linda
  • Loma Linda University Clinical Trial Center, Loma Linda
  • ak 7 plis
Ap rekriteFaz 2
Laj 12 a 17 · Tout sèks · Mizajou Jul 8, 2026 · NCT05287126

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Loma Linda University, Loma Linda
  • Children's Hospital of Orange County, Orange
  • Stanford Children's Health, Palo Alto
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Jun 22, 2026 · NCT06405087

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

  • Amicis Research Center, Valencia
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Jun 12, 2026 · NCT05666960

The Use of Butyrate Therapy in Pediatric Ulcerative Colitis

  • Children's Hospital Los Angeles, Los Angeles
Ap rekriteFaz 2
Laj 7 a 21 · Tout sèks · Mizajou Jun 4, 2026 · NCT05218850

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Rady Children's Hospital - San Diego - PIN, San Diego
Ap rekriteFaz 3
Laj 2 ak plis · Tout sèks · Mizajou May 7, 2026 · NCT05442567

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

  • Investigational Site Number: 8400009, Escondido
  • Investigational Site Number: 8400006, Lancaster
  • Investigational Site Number: 8400025, Thousand Oaks
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Apr 23, 2026 · NCT06975722

Fermented Food-Supplemented Diet in Ulcerative Colitis

  • Stanford University, Palo Alto
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 27, 2026 · NCT04401605

The Influence of a Fasting Mimicking Diet on Ulcerative Colitis

  • Stanford University, Palo Alto
Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou Feb 27, 2026 · NCT03615690

Impact of Prebiotics in Ulcerative Colitis

  • UCLA, Los Angeles
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Feb 27, 2026 · NCT06495658

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

  • University of Los Angeles Health, Los Angeles
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Jan 8, 2026 · NCT05987852

Effects of Pomegranate Juice on Ulcerative Colitis

  • West Los Angeles VA Medical Center, Los Angeles
  • UCLA Center for Human Nutrition, Los Angeles
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 9, 2025 · NCT07115862

Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients

  • University of California San Diego, La Jolla
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou May 16, 2023 · NCT04721873

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.